D-0823-2020 Class III Terminated
FDA drug recall D-0823-2020 was initiated by Macleods Pharma Usa Inc on Jan 20, 2020 and is designated Class III. Reason for recall: Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product The recall status is terminated (terminated Apr 26, 2021). Affected quantity: 10680 units.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 5, 2020
- Initiation Date
- Jan 20, 2020
- Termination Date
- Apr 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10680 units
Product description
Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India NDC 33342-111-10
Reason for recall
Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product
Distribution pattern
Nationwide within the United States
Code information
Lot #: BMD8901B, Exp. Date 02/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0823-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026